Back to search
SARS CoV-2 Post-Acute Sequelae
Clinical trial pipeline · Data from ClinicalTrials.gov
See which SARS CoV-2 Post-Acute Sequelae trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which SARS CoV-2 Post-Acute Sequelae trials you may qualify forGrowing evidence indicates that many people who have chronic post-acute sequelae of SARS-CoV-2 infection (PASC) will experience ongoing neurological and musculo…
Patients with Postural Orthostatic Tachycardia Syndrome (POTS) and Post-Acute Sequelae of COVID (PASC, or "Long COVID") experience cognitive dysfunction. The in…
The purpose of this study is to understand why some people experience long term effects, such as shortness of breath and fatigue, after a severe COVID-19 infect…
While many COVID19 studies are focusing on the immediate biological impact of SARS-CoV2 infection, this multidisciplinary research clinic will inform the global…
Background: SARS-CoV-2 is the virus that causes COVID-19. Some people who recover from COVID-19 have symptoms that last long after the active infection ends. T…
Background: SARS-CoV-2 is the virus that causes COVID-19. Some people who recover from COVID-19 have long-term symptoms that affect the brain. These include he…
Background: SARS-CoV-2 is the virus that causes COVID-19. Some people who recover from an acute COVID-19 infection may continue to have symptoms that persist f…
This is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and comm…